YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

GMED
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

Is it the Right Time to Add Phibro Stock to Your Portfolio?

Phibro Animal Health's PAHC Animal Health segment is gaining momentum from strong legacy demand, Zoetis medicated feed additives (MFA) acquisition and broad product growth. The vaccine business is expanding on higher demand, capacity inves…

finance.yahoo.comPOSITIVO

Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets

Smith+Nephew SNN recently announced the European commercial launch of its CARTIHEAL AGILI-C Cartilage Repair Implant, expanding the availability of its cartilage repair technology across key markets in the region. The launch marks another…

finance.yahoo.comPOSITIVO

Reasons to Retain Hims & Hers Stock in Your Portfolio for Now

Hims & Hers Health HIMS has entered the last quarter of 2026 with strong momentum from weight loss offerings, international expansion and AI-enabled care. However, gross margin pressure from changing business mix, regulatory uncertainty su…

finance.yahoo.comPOSITIVO

10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research

10x Genomics, Inc. TXG recently announced a multi-project research collaboration with Fred Hutchinson Cancer Center to advance single-cell and spatial technologies across solid tumors and blood cancers. The collaboration will focus on biom…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain WAT Stock in Your Portfolio for Now

Waters WAT is well-poised for growth in the coming quarters, driven by sustained demand for analytical sciences, an extended instrument replacement cycle, BD integration and synergies, product innovation and growing opportunities in biosep…

finance.yahoo.comPOSITIVO

Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Split On Outlook

Globus Medical's updated analyst narrative centers on a modest reset in its price target, with the Fair Value estimate moving from US$103.23 to US$100.92. This shift lines up with a split analyst view, where some highlight earnings power a…

finance.yahoo.comPOSITIVO

Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation strategy and growing momentum in HighVolumeHDF and value-based care. However, persistent treatment volume weakness,…

finance.yahoo.comPOSITIVO

BDX Expands U.S. Manufacturing With $19B Healthcare Investment

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a landmark partnership with the U.S. Government to expand domestic manufacturing of essential medical consumables and strengthen healthcare supply-chain resilienc…

finance.yahoo.comPOSITIVO

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid second-quarter fiscal 2027 performance and strength in Health Savings Accounts (HSAs), is expected to contribute further. However, d…

finance.yahoo.comPOSITIVO

Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies

Veeva Systems VEEV continues to strengthen its position in the life sciences software market as its Veeva DQS (Data Quality System) platform expands its reach across clinical trials. The company said that the solution has now supported dat…

finance.yahoo.comPOSITIVO

Reasons to Add Globus Medical Stock to Your Portfolio Now

Globus Medical, Inc. GMED is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments. Also, product innovation and so…

finance.yahoo.comPOSITIVO

Charles River Gains 75.8% in a Year: What's Driving the Rally?

Charles River Laboratories International CRL has witnessed strong momentum over the past year. Shares of the company have risen 75.8%, outperforming the industry's 10.5% growth. The S&P 500 composite has increased 16.1% during the same tim…

finance.yahoo.comPOSITIVO

Is This the Right Time to Add TMO Stock to Your Portfolio?

Thermo Fisher Scientific Inc. TMO is strengthening growth through innovation, artificial intelligence (AI) investments, customer partnerships and a broad commercial engine. Targeted acquisitions are further broadening its capabilities acro…

finance.yahoo.comPOSITIVO

Is It Prudent to Add Teleflex Stock to Your Portfolio Now?

Teleflex's TFX Vascular business is well-positioned for growth in the upcoming quarters, led by sustained demand for central access and hemostatic products, coupled with new product introductions such as EZPLAZ. Further, the company's expa…

finance.yahoo.comPOSITIVO

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

Merit Medical Systems, Inc. MMSI is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by solid product performance, global expansion and strategic M&A, is expected to contribute furt…

finance.yahoo.comPOSITIVO

GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal

GE HealthCare Technologies Inc. GEHC recently announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based contract manufacturing organization (CMO) specializing in PET radiopharmaceuticals, for $945 million in cash. The acq…

finance.yahoo.comPOSITIVO

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

Cardinal Health CAH enters fiscal 2027 with strong momentum across pharmaceutical distribution, specialty solutions and growth businesses. Specialty pharmaceuticals, cell-and-gene therapy capabilities and expanding non-core operations shou…

finance.yahoo.comPOSITIVO

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific

For Immediate Release Chicago, IL – October 6, 2026 – Today, Zacks Equity as Globus Medical GMED, Intuitive Surgical ISRG and Thermo Fisher Scientific TMO. Industry: Medical Instruments Link: https://www.zacks.com/ commentary/2999820/3-med…

finance.yahoo.comPOSITIVO

Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines

Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the medical devices & supplies - speci…

finance.yahoo.comPOSITIVO

Reasons to Retain Doximity Stock in Your Portfolio for Now

Doximity DOCS is entering a pivotal phase as it accelerates investments in artificial intelligence (AI) to expand beyond its core physician engagement platform. While robust physician adoption, growing enterprise AI deployments and excepti…

finance.yahoo.comPOSITIVO

Veeva's OpenData to Help Servier Build a Global AI Data Foundation

Veeva Systems VEEV recently announced that Servier has selected Veeva OpenData to standardize customer reference data across more than 80 countries. The move strengthens Veeva's position as a key provider of data solutions for global life…

finance.yahoo.comPOSITIVO

Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation

Inspire Medical Systems, Inc. INSP recently announced that the American Medical Association's (AMA) CPT Editorial Panel approved new Category I CPT codes for procedures involving a single lead and implantable pulse generator (IPG), includi…

finance.yahoo.comPOSITIVO

3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes

Generative AI (GenAI) is gaining traction across the Medical Instruments industry as companies move from experimentation to practical applications. The technology is being used togenerate synthetic medical images, simulate disease progress…

finance.yahoo.comPOSITIVO

Neogen Stock Rallies 83% YTD: What's Driving the Surge?

Neogen NEOG shares have shown impressive momentum so far this year, surging 83%. The stock has outpaced the industry's 21.6% fall and the S&P 500 composite's 11.7% rise. Carrying a Zacks Rank #2 (Buy) at present, the company's Food Safety…

finance.yahoo.comPOSITIVO

Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care

Smith+Nephew SNN recently launched the new EVOS PELVIC Plating System, expanding its EVOS trauma platform into pelvic and acetabular fracture management. The launch strengthens the company's orthopedic trauma portfolio by adding a dedicate…

finance.yahoo.comPOSITIVO

10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises

10x Genomics, Inc. TXG recently began commercial shipments of Atera, its next-generation spatial biology platform designed to combine whole-transcriptome analysis, sub-cellular resolution and single-cell sensitivity at scale. The launch ma…

finance.yahoo.comPOSITIVO

GMED vs. ITGR: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a close…

finance.yahoo.comPOSITIVO

Should You Continue to Hold IART Stock in Your Portfolio?

Integra LifeSciences Holdings Corporation IART sees steady demand across Specialty Surgery, supported by neurosurgery strength, better supply reliability and emerging ear, nose and throat (ENT) opportunities. The company is improving opera…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

McKesson's MCK prospects are being driven by robust growth in specialty distribution, oncology services and biopharma solutions. Earnings are also improving on the back of ongoing operational efficiency and capital discipline despite persi…

finance.yahoo.comPOSITIVO

1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore

1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense com…

finance.yahoo.comPOSITIVO

Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal

Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated insulin delivery (AID) platform and Senseonics' continuous glucose monitoring technology. The collaboration is expe…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio

Integer Holdings Corporation ITGR has been gaining from its research and product development activities. The optimism, led by a mixed second-quarter 2026 performance and its strength in core product franchises, is expected to contribute fu…

finance.yahoo.comPOSITIVO

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Revvity, Inc. RVTY is well-positioned for growth, thanks to its strong product portfolio. The company is positioned for growth across diagnostics, life sciences and scientific informatics. Diagnostics remains a key growth engine, while new…

finance.yahoo.comPOSITIVO

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth

Fresenius Medical Care AG & Co. FMS recently refined its China commercial strategy to focus on areas offering stronger long-term growth potential and strengthen its position in the country's dialysis market. The company plans to prioritize…

finance.yahoo.comPOSITIVO

Is This the Right Time to Add Labcorp Stock to Your Portfolio?

Labcorp Holdings Inc. LH, or Labcorp, is expanding in high-growth specialty testing markets while broadening its consumer testing business. Acquisitions, health-system relationships and new contracts are boosting the company's reach and su…

finance.yahoo.comPOSITIVO

Globus Medical (GMED) Pulls Back Following Recent Weakness, Is The Stock Trading At A Discount?

Globus Medical (GMED) has drawn investor attention after recent price moves left the stock down about 10% over the past month and roughly 5% lower over the past 3 months. Set against that short term pullback, Globus Medical's 1 year total…